Medicare Enrolled
Dr. Edward Flores, M.D.
Pulmonary Disease · Conroe, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Flores from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Flores?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Flores
Dr. Edward Flores is a pulmonary disease specialist in Conroe, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Flores performed 3,912 Medicare services across 3,197 unique beneficiaries.
Between the years covered by Open Payments, Dr. Flores received a total of $4,236 from 36 pharmaceutical and/or device companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Flores is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in TX
$4,236 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,912
Medicare services
Top 7% in TX for pulmonary disease
3,197
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~206 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
905 | $87 | $270 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
416 | $37 | $165 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
413 | $37 | $161 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
326 | $13 | $59 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
262 | $27 | $184 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
211 | $31 | $158 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
207 | $23 | $93 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
204 | $58 | $183 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
191 | $24 | $105 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
170 | $19 | $109 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
124 | $92 | $387 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
99 | $8 | $18 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $113 | $416 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
45 | $91 | $372 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $82 | $271 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
30 | $35 | $110 |
| Liver function blood test panel | 29 | $8 | $33 |
| Rheumatoid factor analysis | 21 | $6 | $23 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
19 | $4 | $15 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
19 | $5 | $21 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
18 | $62 | $183 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
16 | $8 | $32 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
16 | $57 | $220 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
14 | $32 | $187 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $31 | $76 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
11 | $31 | $76 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,236
Total received (2018-2024)
Avg $605/year across 7 years
Top 37% in TX for pulmonary disease
36
Companies
246
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,996 (94.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$240 (5.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,401
2023
$854
2022
$666
2021
$846
2020
$114
2019
$250
2018
$104
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$1,206
AstraZeneca Pharmaceuticals LP
$1,049
Insmed, Inc.
$211
Regeneron Healthcare Solutions, Inc.
$163
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
Philips Electronics North America Corporation
$128
Mallinckrodt Hospital Products Inc.
$124
United Therapeutics Corporation
$110
Janssen Pharmaceuticals, Inc
$110
Philips North America LLC
$99
GENZYME CORPORATION
$89
Grifols USA, LLC
$85
Sunovion Pharmaceuticals Inc.
$71
PFIZER INC.
$69
Bayer Healthcare Pharmaceuticals Inc.
$68
Genentech USA, Inc.
$42
Takeda Pharmaceuticals U.S.A., Inc.
$40
ANI Pharmaceuticals, Inc.
$40
Electromed, Inc.
$39
Baxter Healthcare
$36
Actelion Pharmaceuticals US, Inc.
$30
LEO Pharma Inc.
$30
Amgen Inc.
$29
Merck Sharp & Dohme LLC
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$25
Allergan Inc.
$24
Vifor Pharma, Inc.
$22
HARMONY BIOSCIENCES LLC
$21
ADVANCED RESPIRATORY, INC
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Lilly USA, LLC
$15
Otsuka America Pharmaceutical, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Mylan Specialty L.P.
$12
Inogen, Inc.
$8
Top 3 companies account for 58.2% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · ADBRY · AIRSUPRA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · DUPIXENT · ELIQUIS · EVENITY · Enbrel · Esbriet · FASENRA · GLASSIA · Hillrom - Vest System Model 105 Home Care · InogenOne · Kerendia · LIBTAYO · LONHALA MAGNAIR · MOUNJARO · NUCALA · OFEV · OPSUMIT · ORENITRAM · PAXLOVID · PNEUMOVAX 23 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · REMODULIN · REXULTI · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Monarch Airway Clearance System · WAKIX · Wellcentive Undiv · XARELTO · XIFAXAN · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $108 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
17
Per 100K population
2.6
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Flores is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Flores experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Flores performed 905 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Flores receive payments from pharmaceutical companies?
Yes. Dr. Flores received a total of $4,236 from 36 companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Flores's costs compare to other pulmonary diseases in Conroe?
Dr. Flores's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Flores) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Conroe
Browse pulmonary diseases in Conroe ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology